Lidocain Braun (Lidocaine Hydrochloride Monohydrate)

Lidocaine blocks voltage‑gated sodium channels on nerve membranes, preventing the initiation and spread of action potentials. This stabilizes neuronal membranes and stops nerve impulse transmission, resulting in reversible loss of sensation in the area where it is administered.

The dose of Lidocain Braun is determined by the prescribing clinician based on the procedure, patient weight, age, and clinical condition. Healthcare professionals calculate the appropriate volume and concentration to achieve effective anesthesia while minimizing toxicity.

Safety data for lidocaine use in pregnancy and lactation are limited. It may be used when the potential benefit justifies the potential risk to the fetus or infant. The prescriber should evaluate individual circumstances and follow local regulatory guidance.

To order Lidocain Braun, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Lidocaine has a rapid onset (1–3 minutes) and intermediate duration (30–120 minutes), whereas bupivacaine has a slower onset but longer duration (up to several hours). Lidocaine is often chosen for procedures requiring quick recovery, while bupivacaine is preferred for prolonged analgesia. Both share similar safety profiles but differ in potency and duration.

Lidocain Braun should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme temperature fluctuations. Do not freeze. Inspect the solution for particulate matter or discoloration before use.

Lidocain Braun is administered by a qualified healthcare professional via epidural, intradermal or subcutaneous injection. The appropriate concentration and volume are selected based on the target tissue and procedural requirements. Standard aseptic technique and proper needle placement are essential for safe administration.

Serious risks include systemic toxicity manifesting as seizures, cardiac arrhythmias, severe hypotension, respiratory depression, and allergic reactions such as anaphylaxis. Early signs of toxicity—such as tinnitus, metallic taste, or circumoral numbness—should prompt immediate medical evaluation.

Patients with known hypersensitivity to lidocaine or other amide‑type local anesthetics should avoid Lidocain Braun. Caution is also advised for individuals with severe hepatic impairment, certain cardiac conduction disorders, or those taking medications that markedly increase lidocaine plasma levels. The prescriber decides suitability on a case‑by‑case basis.